The Risks And Perils Of Crowdfunding

Krist Werling, Bob Cohen, Michael Pilo | Genetic Engineering & Biotechnology News | March 1, 2013

Crowdfunding could revolutionize fundraising for early-stage biotech companies, but beware of the pitfalls.

Since the passage of the Jumpstart Our Business Startups (JOBS) Act (H.R. 3606) last year, the financial and medical press has been buzzing about the potential for crowdfunding to revolutionize fundraising for early-stage biotech companies. Even more recently, a portal that is exclusively dedicated to crowdfunding biotech and healthcare start-ups launched at Although there may be reason for biotech entrepreneurs to be excited about crowdfunding, there are significant limitations and risks to this approach as well.